Mette Kjær

525 total citations
16 papers, 290 citations indexed

About

Mette Kjær is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Mette Kjær has authored 16 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 5 papers in Genetics and 4 papers in Surgery. Recurrent topics in Mette Kjær's work include Platelet Disorders and Treatments (13 papers), Blood groups and transfusion (11 papers) and Blood disorders and treatments (5 papers). Mette Kjær is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Blood groups and transfusion (11 papers) and Blood disorders and treatments (5 papers). Mette Kjær collaborates with scholars based in Norway, Sweden and United States. Mette Kjær's co-authors include Jens Kjeldsen‐Kragh, James B. Bussel, Michael Murphy, Donald M. Arnold, Bjøŕn Skogen, Dick Oepkes, Shoma Baidya, Andreas Greinacher, Lani Lieberman and Edwin Massey and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mette Kjær

15 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mette Kjær Norway 11 242 102 52 39 27 16 290
Dian Winkelhorst Netherlands 10 219 0.9× 100 1.0× 41 0.8× 28 0.7× 35 1.3× 15 258
Shoma Baidya Australia 8 195 0.8× 74 0.7× 37 0.7× 16 0.4× 22 0.8× 16 243
Heidi Tiller Norway 12 384 1.6× 172 1.7× 49 0.9× 69 1.8× 27 1.0× 29 418
Ety Zwang Israel 8 213 0.9× 34 0.3× 23 0.4× 44 1.1× 10 0.4× 10 302
C Patereau France 9 328 1.4× 149 1.5× 50 1.0× 15 0.4× 11 0.4× 17 346
Boonchai Boonyawat Thailand 8 140 0.6× 30 0.3× 44 0.8× 13 0.3× 30 1.1× 22 226
Rafael Parra Spain 8 118 0.5× 61 0.6× 19 0.4× 4 0.1× 11 0.4× 10 203
Dilara Fatma Kocacık Uygun Türkiye 7 40 0.2× 104 1.0× 174 3.3× 20 0.5× 5 0.2× 25 267
Giorgia Bucciol Belgium 9 24 0.1× 63 0.6× 148 2.8× 9 0.2× 9 0.3× 15 226
Marjory Stroup United States 11 249 1.0× 82 0.8× 36 0.7× 3 0.1× 41 1.5× 27 294

Countries citing papers authored by Mette Kjær

Since Specialization
Citations

This map shows the geographic impact of Mette Kjær's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Kjær with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Kjær more than expected).

Fields of papers citing papers by Mette Kjær

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette Kjær. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Kjær. The network helps show where Mette Kjær may publish in the future.

Co-authorship network of co-authors of Mette Kjær

This figure shows the co-authorship network connecting the top 25 collaborators of Mette Kjær. A scholar is included among the top collaborators of Mette Kjær based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette Kjær. Mette Kjær is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Geisen, Christof, Carmen Walter, Jens Søndergaard Jensen, et al.. (2024). A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention. Thrombosis and Haemostasis. 125(4). 352–363.
2.
Geisen, Christof, Mette Kjær, Bjøŕn Skogen, et al.. (2023). An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study. Journal of Thrombosis and Haemostasis. 21(4). 838–849. 3 indexed citations
3.
Geisen, Christof, Carmen Walter, Stefan Braeuninger, et al.. (2023). OC 02.1 Dose-Dependent Elimination of HPA-1a Platelets by Subcutaneous RLYB212, a Monoclonal Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 7. 100679–100679. 1 indexed citations
4.
Dahl, Jesper, Bjøŕn Skogen, Mette Kjær, et al.. (2020). A combined effect of anti‐HPA‐1a and anti‐HLA Class I in pregnancy?. Transfusion. 60(9). 2121–2129. 3 indexed citations
5.
Averina, Maria, Tor Hervig, Sandra Huber, et al.. (2020). Environmental pollutants in blood donors: The multicentre Norwegian donor study. Transfusion Medicine. 30(3). 201–209. 12 indexed citations
6.
Lieberman, Lani, Andreas Greinacher, Michael Murphy, et al.. (2019). Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach. British Journal of Haematology. 185(3). 549–562. 49 indexed citations
7.
Kjær, Mette, Christof Geisen, Çiğdem Akalın Akkök, et al.. (2019). Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia. Transfusion and Apheresis Science. 59(1). 102712–102712. 12 indexed citations
8.
Kjeldsen‐Kragh, Jens, et al.. (2019). HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a–immunized women. Blood Advances. 3(7). 945–951. 18 indexed citations
9.
Baker, Jillian M., Nadine Shehata, James B. Bussel, et al.. (2019). Postnatal intervention for the treatment of FNAIT: a systematic review. Journal of Perinatology. 39(10). 1329–1339. 11 indexed citations
10.
Kjær, Mette, Gérald Bertrand, Tamam Bakchoul, et al.. (2018). Maternal HPA‐1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. Vox Sanguinis. 114(1). 79–94. 35 indexed citations
11.
Tiller, Heidi, Yan Zhou, Iñigo Martínez-Zubiaurre, et al.. (2017). Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model. Reproductive Biology and Endocrinology. 15(1). 28–28. 19 indexed citations
12.
Winkelhorst, Dian, Michael Murphy, Andreas Greinacher, et al.. (2017). Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review. Blood. 129(11). 1538–1547. 75 indexed citations
13.
Husebekk, Anne, et al.. (2016). Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia. PLoS ONE. 11(9). e0162973–e0162973. 3 indexed citations
14.
Tiller, Heidi, Maria Averina, Mette Kjær, et al.. (2015). Characterization of a Human Platelet Antigen-1a–Specific Monoclonal Antibody Derived from a B Cell from a Woman Alloimmunized in Pregnancy. The Journal of Immunology. 194(12). 5751–5760. 22 indexed citations
15.
Tiller, Heidi, Anne Husebekk, Bjøŕn Skogen, Jens Kjeldsen‐Kragh, & Mette Kjær. (2015). True risk of fetal/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow‐up study. BJOG An International Journal of Obstetrics & Gynaecology. 123(5). 738–744. 17 indexed citations
16.
Marston, Barbara J., Lucy Nganga, Festus Ilako, et al.. (2007). A Program to Provide Antiretroviral Therapy to Residents of an Urban Slum in Nairobi, Kenya. Journal of the International Association of Physicians in AIDS Care. 6(2). 106–112. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026